Product Information
ANGELIQ 0.5 MG-1 MG TABLET is a brand product labeled by Bayer HealthCare Pharmaceuticals Inc., priced at $6.3667 per EA under NDC 50419048303. Its NADAC has been published 450 times since Nov 28, 2013.
FDA first approved this application on Sep 28, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5; 1 mg/1; mg/1
Manufacturer
Bayer HealthCare Pharmaceuticals Inc.NDC
50419048303
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DROSPIRENONE; ESTRADIOLApproval Type
New Drug (NDA)
FDA Application
NDA021355FDA Approved
9/28/2005
TE Code
AB
On Market Since
11/28/2005
Price Statistics
The NADAC for ANGELIQ 0.5 MG-1 MG TABLET has been published 450 times since Nov 28, 2013, and over the history we have for it it has risen 84.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3667 per EA |
|---|---|
| All-time high | $6.3941 (Jan 15, 2020) |
| All-time low | $3.4529 (Nov 28, 2013) |
| 52-week high | $6.3743 |
| 52-week low | $6.3502 |
| Median price | $6.0895 |
| Average price | $5.3604 |
| Largest weekly change | +9.9% (Jan 3, 2018) |
| Weeks tracked | 450 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the drospirenone and estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bayer HealthCare Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
drospirenone and estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANGELIQ 0.5 MG-1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ANGELIQ 0.5 MG-1 MG TABLET, manufactured by Bayer HealthCare Pharmaceuticals Inc., is $6.3667 per EA (NDC 50419048303), effective Sep 30, 2026.
How has the price of ANGELIQ 0.5 MG-1 MG TABLET changed over time?
Over the history we have for it, the NADAC for ANGELIQ 0.5 MG-1 MG TABLET has risen 84.4%. It has been tracked across 450 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ANGELIQ 0.5 MG-1 MG TABLET?
Since Nov 28, 2013, the NADAC for ANGELIQ 0.5 MG-1 MG TABLET has ranged from a low of $3.4529 (Nov 28, 2013) to a high of $6.3941 (Jan 15, 2020), with a median of $6.0895 per EA.
Are there cheaper alternatives to ANGELIQ 0.5 MG-1 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ANGELIQ 0.5 MG-1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ANGELIQ 0.5 MG-1 MG TABLET?
ANGELIQ 0.5 MG-1 MG TABLET (NDC 50419048303) is labeled by Bayer HealthCare Pharmaceuticals Inc., and CMS classifies it as a brand product.